Collaborative Care for Treatment of Depression and Anxiety
2 other identifiers
observational
200
1 country
1
Brief Summary
The goal of this project is to evaluate the effectiveness of a collaborative care model for primary care patients at Kaiser Permanente Colorado (KPCO) with depression and/or anxiety. Collaborative care uses evidence-based short-term treatments delivered to patients over the phone. We will explore the use of cost-efficient automated processes for patient outreach and follow-up, such as care pools of patients and using patient portal messaging, risk-based results routing to providers, and electronic health record (EHR) tools for patient tracking and outcome assessment. Using a cluster randomized design, we will compare results between clinics that are offering collaborative care to those that are not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 12, 2024
CompletedFirst Posted
Study publicly available on registry
August 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedAugust 16, 2024
August 1, 2024
1.6 years
July 12, 2024
August 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient Health Questionnaire 9-item (PHQ-9) score
Change in Patient Health Questionnaire 9-item (PHQ-9) scores before and after Collaborative Care intervention. The score ranges from 0 to 27, with lower numbers indicating improvement in depression symptoms.
Baseline and up to 24 weeks
Generalized Anxiety Disorder 7-item (GAD-7)
Generalized Anxiety Disorder 7-item (GAD-7) questionnaire scores before and after Collaborative Care intervention. The score ranges from 0 to 21, with lower numbers indicating improvement in anxiety symptoms.
Baseline and up to 24 weeks
Study Arms (2)
Collaborative Care offered
Implement collaborative care in at least 2 clinic locations for patients with depression and/or anxiety using population-based outreach using electronic health record tools and provider referral, and tracking outcomes in the medical record.
No Collaborative Care offered
Provide care as usual for patients with depression and/or anxiety at all other KPCO clinics.
Interventions
Collaborative care components include patient-centered team care, population-based care, measurement-based treatment to target, evidence-based care, and accountable care.
Eligibility Criteria
Patients with depression and/or anxiety.
You may qualify if:
- Current membership and active on patient portal
- Depression Diagnosis in the prior year
- Overdue for PHQ9 Screening based on the following criteria:
- High Risk: Last PHQ9 screener was completed greater than 4 months ago AND total Score is greater than or equal 10 or item 9 is greater than 0.
- Low Risk: Last PHQ9 screener was completed greater than 12 months ago AND Last PHQ9 Total Score is less than 10 and item 9 is equal to 0.
- Anxiety diagnoses in the prior year
- Has a baseline GAD7 in the same prior year; score = 10+ (\*Note: Provider referrals could be GAD7 score of 7 or higher)
- No Behavioral Health (BH) engagement in the prior year
- Patient is not in a Skilled Nursing Facility or Hospice
- Patient has no record of psychiatric hospitalization in the last year
- Patient does not need an interpreter (i.e., English speaking)
- Primary care location is one of the intervention clinics
You may not qualify if:
- Exclude individuals with any of the following diagnoses:
- Psychosis
- Dementia
- Bipolar
- Personality Disorders
- Post Traumatic Stress Disorder (PTSD)
- Obsessive Compulsive Disorder (OCD)
- Panic Disorder
- Cognitive Disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- Garfield Memorial Fundcollaborator
Study Sites (1)
Kaiser Permanente Colorado
Aurora, Colorado, 80011, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2024
First Posted
August 16, 2024
Study Start
March 1, 2023
Primary Completion
September 30, 2024
Study Completion
March 31, 2025
Last Updated
August 16, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share